Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Generics
Pharma
Biogen places chips behind 4 new drugs as MS competition mounts
As multiple sclerosis generic competition heats up, Biogen is putting its chips behind four new drugs: Leqembi, Skyclarys, Qalsody and Zurzuvae.
Fraiser Kansteiner
Feb 12, 2025 11:35am
Novartis wins 11th-hour bid to block Entresto generic from MSN
Jan 17, 2025 11:41am
Teva, Takeda divest generics joint venture in Japan
Dec 6, 2024 10:53am
Novartis' latest bid to block MSN's generic comes up short
Dec 5, 2024 12:22pm
Roche files patent suit to fend off potential Evrysdi generics
Nov 20, 2024 9:44am
BeiGene defends Brukinsa from MSN's generic threat until 2037
Nov 19, 2024 3:55pm
